MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-01-31, PBSV has $13,548,426 in assets. $3,309,695 in debts.

Balance Sheets Overview

Current Ratio
402.57%
Quick Ratio
402.57%
Debt to Asset Ratio
24.43%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Retained earnings
    • Dividend payable to shareholders
    • Additional paid-in capital
    • Others

Balance Sheets
2026-01-31
2025-10-31
2025-07-31
Cash and cash equivalents
5,763,618 3,379,212 3,957,752
Marketable securities
4,796,568 7,475,377 6,767,282
Accounts receivable
2,654,675 2,360,682 2,015,529
Prepaids and other assets
109,108 171,574 415,093
Total current assets
13,323,969 13,386,845 13,155,656
Property and equipment
103,674 116,059 131,526
Operating lease right-of-use
0 29,388 72,747
Other assets
120,783 120,754 225,649
Total assets
13,548,426 13,653,046 13,585,578
Current operating lease liabilities
0 28,834 71,362
Accounts payable and accrued expenses
869,964 991,169 874,379
Dividend payable to shareholders
1,717,627 --
Current portion of us tax reform transition tax and income taxes payable
722,104 718,796 713,153
Total current liabilities
3,309,695 1,738,799 1,658,894
Us tcja transition tax payable
-0 0
Long term operating lease liabilities
-0 0
Total liabilities
3,309,695 1,738,799 1,658,894
Common stock, 0.0001 par value authorized 50,000,000 shares 23,519,672 and 23,519,672 shares issued, and 22,902,892 and 22,905,992 shares outstanding on january 31, 2026 and october 31, 2025, respectively
2,352 2,352 2,352
Additional paid-in capital
1,688,166 1,679,547 1,675,148
Retained earnings
8,848,822 10,533,589 10,533,691
Accumulated other comprehensive income
280,358 278,045 285,577
Stockholders' equity before treasury stock
10,819,698 12,493,533 -
Treasury stock, at cost 613,680 and 561,529 common shares held on october 31, 2025 and 2024, respectively
-579,286 -
Treasury stock, at cost 616,780 and 613,680 common shares held on january 31, 2026 and october 31, 2025, respectively
580,967 -570,084
Total stockholders' equity
10,238,731 11,914,247 11,926,684
Total liabilities and stockholders' equity
13,548,426 13,653,046 13,585,578
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$5,763,618 Marketable securities$4,796,568 Accounts receivable$2,654,675 Prepaids and other assets$109,108 Total current assets$13,323,969 Other assets$120,783 Property and equipment$103,674 Total assets$13,548,426 Total liabilities andstockholders' equity$13,548,426 Total stockholders'equity$10,238,731 Total liabilities$3,309,695 Treasury stock, at cost616,780 and 613,680...$580,967 Stockholders' equity beforetreasury stock$10,819,698 Total currentliabilities$3,309,695 Retained earnings$8,848,822 Additional paid-in capital$1,688,166 Accumulated othercomprehensive income$280,358 Common stock, 0.0001par value...$2,352 Dividend payable toshareholders$1,717,627 Accounts payable andaccrued expenses$869,964 Current portion of us taxreform transition tax...$722,104

Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv, Inc. (PBSV)